Cellyan Biotechnology
HKPD----
Q2 FY2026 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Cellyan Biotechnology(HKPD) the Revenue is 3.569 M (-35.65%);the EBIT is 105.73 K (-79.38%);the EPS is 0.007 (-83.13%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B35.65%
----
----
EBIT
0.00B79.38%
----
----
EPS
0.00783.13%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf